Eva Řezníčková

7PUBLICATIONS
31CO-AUTHORS
Biologically active moleculesCheminformatics and quantitative structure-activity relationshipsFlight dynamicsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 26, 2026
First-in-Class Dual PDGFR/Carbonic Anhydrase IX/XII Inhibitors: 6,7-Dimethoxyquinoline-Sulfonamides as Promising Antileukemic Agents.

Eslam Roshdy, Eva Řezníčková, Mostafa M Elbadawi

|Dec 24, 2024
Strategies for the treatment of acute myeloid leukemia with FLT3 mutations: a patent review.

Lukas Gorecki, Eva Reznickova, Vladimir Krystof

|Jul 05, 2024
Synthesis and photodynamic activity of new 5-[(E)-2-(3-alkoxy-1-phenyl-1H-pyrazol-4-yl)ethenyl]-2-phenyl-3H-indoles.

Gabrielė Varvuolytė, Eva Řezníčková, Aurimas Bieliauskas

|Aug 03, 2023
Inhibition of FLT3-ITD Kinase in Acute Myeloid Leukemia by New Imidazo[1,2-b]pyridazine Derivatives Identified by Scaffold Hopping.

Petra Břehová, Eva Řezníčková, Kryštof Škach

|Dec 23, 2022
Synthesis and Structural Optimization of 2,7,9-Trisubstituted purin-8-ones as FLT3-ITD Inhibitors.

Monika Tomanová, Karolína Kozlanská, Radek Jorda

Pageof 2